Yifang Bio Stock Plunges 30%: Is the AI Drug Discovery Sector Losing Steam?
In the spring of 2026, Yifang Bio — once hailed as the 'Disneyland of Pharma' — saw its stock price plunge over 30%, tri…
🏷️ innovative drugs
2 articles about 'innovative drugs'
RemeGen Q1 Net Profit Reaches 328 Million Yuan, Swinging From Loss to Profit
RemeGen released its Q1 2026 earnings report, posting revenue of 656 million yuan, a year-over-year increase of 24.76%, …
1